Cost-effectiveness analysis of treatment of E. histolytica/E. dispar cyst carriers.
Garduño-Espinosa
J
J
Unidad de Investigación, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, México, D.F., Mexico.
Martínez-García
M C
MC
Valadez-Salazar
A
A
Padilla
G
G
Cedillo-Rivera
R
R
Muñoz
O
O
D000818:Animals; D002353:Carrier State / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology / Q000469:parasitology; D003362:Cost-Benefit Analysis; D004747:Entamoeba / Q000254:growth & development / Q000302:isolation & purification*; D004748:Entamoeba histolytica / Q000254:growth & development / Q000302:isolation & purification*; D004749:Entamoebiasis / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology / Q000469:parasitology; D006801:Humans; D008800:Mexico / Q000453:epidemiology; D015995:Prevalence